Dr Danny Hsu is a consultant laboratory and clinical haematologist based at Liverpool Hospital, Sydney, Australia. He is the Clinical Lead of Immune Haematology and the Director of Therapeutic Apheresis. Dr Hsu is also a Conjoint Senior Lecturer of the Clinical School of Medicine at the University of New South Wales. He is also a sitting council member of the Thrombosis Haemostasis society of Australia and New Zealand (THANZ). Dr Hsu’s main clinical and research interests are in the field of immune haematology, complementopathies, and thrombotic microangiopathies
